Skip to main content
FDMT logo

FDMT · 4D Molecular Therapeutics, Inc. · Investor Relations

Track FDMT — free
$12.55 +0.59 (+4.94%)
Market Cap
$863.27M
Shares
72.18M
Volume · Oct 28 1.19M Avg daily vol (3M) 996.05K

Press releases and events scraped from the company’s investor relations website. Past events open our own call or event page when we host one; otherwise listings link to the original source.

Past events

Date Event Type
2026-10-21 Investor Day in New York City Presentation
2026-09-14 Morgan Stanley 24th Annual Global Healthcare Conference Conference
2026-09-10 2026 Cantor Global Healthcare Conference Conference
2026-09-09 Wells Fargo 2026 Healthcare Conference Conference
2026-06-09 Goldman Sachs 47th Annual Global Healthcare Conference Conference
2026-06-03 Jefferies Global Healthcare Conference Conference
2026-05-19 RBC 2026 Global Healthcare Conference Conference
2026-05-13 BofA Securities 2026 Healthcare Conference Conference
2026-03-25 Leerink Partners Mountain Meeting Event
2026-03-24 RBC Capital Markets Global Ophthalmology Conference Conference
2026-03-12 Barclays 28th Annual Global Healthcare Conference Conference
2026-03-10 Leerink Global Healthcare Conference Conference
2026-03-03 TD Cowen 46th Annual Health Care Conference Conference
2026-01-14 44th Annual J.P. Morgan Healthcare Conference Conference
2025-12-17 AEROW Phase 1 Interim Data for 4D-710 in Cystic Fibrosis Earnings call
2025-12-03 8th Annual Evercore Healthcare Conference Conference
2025-11-18 Jefferies 2025 London Healthcare Conference Conference
2025-10-21 Chardan’s 9th Annual Genetic Medicines Conference Conference
2025-09-09 Morgan Stanley Annual Global Healthcare Conference Conference
2025-09-09 H.C. Wainwright 27th Annual Global Investment Conference Conference
2025-09-04 Cantor Global Healthcare Conference 2025 Conference
2025-08-13 H.C. Wainwright 5th Annual Ophthalmology Virtual Conference Conference
2025-06-11 46th Annual Goldman Sachs Global Healthcare Conference Conference
2025-06-04 Jefferies Global Healthcare Conference Conference
2025-05-14 BofA Securities 2025 Healthcare Conference Conference

Source: https://ir.4dmoleculartherapeutics.com/

Key facts CIK 1650648 CUSIP 35104E100 13F (30d) 20 filings 20 filers Visit website Investor relations